XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

4. Fair Value of Financial Instruments

The following tables summarize the fair value of the Company’s financial instruments (in thousands):

 

 

 

 

 

 

Fair Value Measurements Using

 

 

 

March 31,
2022

 

 

Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

35,047

 

 

$

35,047

 

 

$

 

 

$

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

97,965

 

 

$

 

 

$

97,965

 

 

 

 

Commercial paper

 

 

21,287

 

 

 

 

 

 

21,287

 

 

 

 

U.S. Government securities

 

 

56,094

 

 

 

 

 

 

56,094

 

 

 

 

Total short-term investments

 

 

175,346

 

 

 

 

 

 

175,346

 

 

 

 

Total

 

$

210,393

 

 

$

35,047

 

 

$

175,346

 

 

$

 

 

 

 

 

 

 

Fair Value Measurements Using

 

 

 

December 31,
2021

 

 

Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

57,018

 

 

$

57,018

 

 

$

 

 

$

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

111,466

 

 

$

 

 

$

111,466

 

 

 

 

Commercial paper

 

 

21,272

 

 

 

 

 

 

21,272

 

 

 

 

U.S. Government securities

 

 

44,534

 

 

 

 

 

 

44,534

 

 

 

 

Total short-term investments

 

 

177,272

 

 

 

 

 

 

177,272

 

 

 

 

Total

 

$

234,290

 

 

$

57,018

 

 

$

177,272

 

 

$

 

Cash Equivalents and Short-Term Investments

Financial assets measured at fair value on a recurring basis consist of the Company’s cash equivalents and short-term investments. Cash equivalents consisted of money market funds and short-term investments consisted of commercial paper, U.S. Government securities and corporate bonds. The Company obtains pricing information from its investment manager and generally determines the fair value of investment securities using standard observable inputs, including reported trades, broker/dealer quotes, and bids and/or offers.

Investments are classified as Level 1 within the fair value hierarchy if their quoted prices are available in active markets for identical securities. Investments in money market funds of $35.0 million and $57.0 million as of March 31, 2022 and December 31, 2021, respectively, were classified as Level 1 instruments and were included in cash and cash equivalents.

Investments in marketable securities are valued using Level 2 inputs. Level 2 securities are initially valued at the transaction price and subsequently valued and reported upon utilizing inputs other than quoted prices that are observable either directly or indirectly, such as quotes from third-party pricing vendors. Fair values determined by Level 2 inputs, which utilize data points that are observable such as quoted prices, interest rates and yield curves, require the exercise of judgment and use of estimates, that if changed, could significantly affect the Company’s financial position and results of operations. The marketable securities of $175.3 million and $177.3 million as of March 31, 2022 and December 31, 2021, respectively, were classified as Level 2 instruments and were included in short-term investments. Accrued interest receivable related to short-term investments was $1.0 million as of both March 31, 2022 and December 31, 2021 and included as part of prepaid expenses and other current assets in the condensed balance sheets.

The following tables summarize the Company’s short-term investments accounted for as available-for-sale securities as of March 31, 2022 and December 31, 2021 (in thousands):

 

 

 

 

 

March 31, 2022

 

 

 

Maturity
(in years)

 

Amortized
Cost

 

 

Unrealized
Losses

 

 

Unrealized
Gains

 

 

Estimated
Fair Value

 

Corporate debt securities

 

1 year or less

 

$

98,273

 

 

$

(312

)

 

$

4

 

 

$

97,965

 

Commercial paper

 

1 year or less

 

 

21,287

 

 

 

 

 

 

 

 

 

21,287

 

U.S. Government securities

 

1 year or less

 

 

56,392

 

 

 

(298

)

 

 

 

 

 

56,094

 

Total

 

 

 

$

175,952

 

 

$

(610

)

 

$

4

 

 

$

175,346

 

 

 

 

 

 

December 31, 2021

 

 

 

Maturity
(in years)

 

Amortized
Cost

 

 

Unrealized
Losses

 

 

Unrealized
Gains

 

 

Estimated
Fair Value

 

Corporate debt securities

 

1 year or less

 

$

111,548

 

 

$

(89

)

 

$

7

 

 

$

111,466

 

Commercial paper

 

1 year or less

 

 

21,272

 

 

 

 

 

 

 

 

 

21,272

 

U.S. Government securities

 

1 year or less

 

 

44,602

 

 

 

(68

)

 

 

 

 

$

44,534

 

Total

 

 

 

$

177,422

 

 

$

(157

)

 

$

7

 

 

$

177,272

 

 

The Company has classified all of its available-for-sale investment securities as current assets on the condensed balance sheets based on the highly liquid nature of these investment securities and because these investment securities are considered available for use in current operations.

The Company considers whether unrealized losses have resulted from a credit loss or other factors. The unrealized losses on the Company’s available-for-sale securities as of March 31, 2022 and December 31, 2021 were caused by fluctuations in market value and interest rates as a result of the economic environment and not credit risk. The Company concluded that an allowance for credit losses was unnecessary as of March 31, 2022 and that there were no impairments as of December 31, 2021. It is neither management’s intention to sell nor is it more likely than not that the Company will be required to sell these investments prior to recovery of their cost basis or recovery of fair value. Unrealized gains and losses are included in accumulated other comprehensive loss.

There was no realized gain or loss on available-for-sale securities in the periods presented. The Company uses the specific identification method to determine the cost basis of investments sold.